Pharmacokinetics in children
All active ingredients act locally in the colon and are not absorbed in detectable amounts.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Laxative as preparation for surgery, X-ray or endoscopic examination of the colon |
- Oral
-
1 year
up to
2 years
-
2.5
mg/dose
1st dose: 10-18 hours prior to procedure
2nd dose: 4-6 hours prior to procedure.
-
2 years
up to
4 years
-
5
mg/dose
1st dose: 10-18 hours prior to procedure
2nd dose: 4-6 hours prior to procedure.
-
4 years
up to
9 years
-
9 years
up to
18 years
-
10
mg/dose
1st dose: 10-18 hours prior to procedure
2nd dose: 4-6 hours prior to procedure.
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
DRUGS FOR CONSTIPATION
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Softeners, emollients |
|
|
|
A06AA01
|
| Contact laxatives |
|
|
|
A06AB02
|
|
|
|
A06AB08
|
|
|
|
A06AB06
|
|
|
|
A06AB06
|
| Bulk-forming laxatives |
|
|
|
A06AC01
|
| Osmotically acting laxatives |
|
|
|
A06AD12
|
|
|
|
A06AD11
|
|
|
|
A06AD65
|
|
|
|
A06AD65
|
|
|
|
A06AD15
|
|
|
|
A06AD65
|
| Enemas |
|
|
|
A06AG
|
|
|
|
A06AG10
|
|
|
|
A06AG10
|
|
|
|
A06AG04
|
|
|
|
A06AG11
|
|
|
|
A06AG01
|
| Other drugs for constipation |
|
|
|
A06AX01
|
|
|
|
A06AX02
|
References
-
Pinfield A. et al, Randomised trial of two pharmacological methods of bowel preparation for day case colonoscopy., Arch Dis Child, 1999, 80(2), 181-3
-
Ferring BV, SPC Picoprep (RVG 106616) 17-06-2016, www.cbg-meb.nl
-
MMI, Gelbe Liste I Online Laxoberal® Abführ-Tabletten, 5 mg Tabletten, 06/2018
-
Ferring, SmPC Picoprep 10mg Pulver zur Herstllung einer Lösung zum Einnehmen (79572.00.00), 06/2016
-
Sanofi, SmPC Laxoberal 2,5mg Weichkapseln (6926.00.04), 03/2007
-
Sanofi, SmPC Laxoberal 7,5mg/ml Tropfen zum Einnehmen_Laxoberal 5mg Tabletten (6926.00.01_6926.00.00), 07/2017
-
Sanofi, SmPC Dulcolax NP Kinder 7,5mg/ml Tropfen zum Einnehmen (22254.00.00), 06/2017
-
MEDA, SmPC Agiolax Pico 5mg Abführ-Pastillen (6520998.00.00), 04/2015
-
Krewel Meuselbach, SmPC Regulax Picosulfat 10mg Würfel (6751605.00.01), 08/2013
-
Krewel Meuselbach, SmPC Regulax 7,23mg/ml Tropfen (6751605.00.00), 03/2013
-
DAZ.online., Individuell für Kinder: Einige Besonderheiten der paediatrischen Rezeptur. , 05/2018
-
Breitkreutz J BJ., Paediatric and geriatric drug delivery. Expert opinion on drug delivery, 2007, 4, 37-45
-
DAZ.online., Individuell für Kinder: Einige Besonderheiten der paediatrischen Rezeptur., 05/2018
Therapeutic Drug Monitoring
Overdose